Hydroxamic acid tetrapeptide derivatives

FIELD OF THE INVENTION
The present invention relates to new peptidylhydroxamic acid derivatives which specifically inhibit the action of collagenase of vertebrate origin, as well as to collagenase inhibitors containing these new peptidylhydroxamic acid derivatives as active ingredient.
1. Background Art
Collagenase is an enzyme which decomposes collagen, one of the main protein components constituting connective tissues.
Animals in pathological conditions show an abnormal overaction of collagenase in processes of the destruction and repair of tissues. Such abnormal overaction of collagenase is observed, for example, in such cases as rheumatoid arthritis, peridental diseases, corneal ulcer and epidermolysis bullosa, where inhibition of the action of collagenase provides a useful means for treating such diseases.
2. Prior Art
Some peptidylhydroxamic acids have heretofore been known as substances which exhibit inhibitory action on collagenase. Thus, William M. Moore et al. reported benzyloxycarbonyl-prolyl-leucyl-glycylhydroxamic acid (Z-Pro-Leu-Gly-NHOH) (see William M. Moore and Curtis A. Spilburg, Biochemical and Biophysical Research Communications, Vol. 136, No. 1, Pages 390-395, 1986). Furthermore as other peptide-based synthetic collagenase inhibitors were reported mercapto-containing compounds (see Robert D. Gray, Hossain H. Saneii and Arno F. Spatola, Biochemical and Biophysical Research Communications, Vol. 101, No. 4, Pages 1251-1258, 1981; Charles F. Vencill, David Rasnick, Katherine V. Crumley, Norikazu Nishino and James C. Powers, Biochemistry 24, 3149-3157, 1985) or carboxyl group-containing compounds (see Jean-Marie Delaisse, Yves Eeckhout, Christopher Sear, Alan Galloway, Keith McCullagh and Gilbert Vaes, Biochemical and Biophysical Research Communications, Vol. 133, No. 2, Pages 483-490, 1985).
The purpose of the present invention is to provide new peptide compounds which selectively inhibit the action of collagenase derived from vertebrates without inhibiting other protease actions (i.e. which exhibit an inhibitory action of high specificity), and which have low toxicity, improved metabolic rate and other improved properties.
The present inventors, as a result of extensive researches aiming at developing new peptide compounds with such preferable properties have achieved the present invention, according to which it has been found that new peptidylhydroxamic acid derivatives of the general formula (I):
X.sup.1 -X.sup.2 -X.sup.3 -X.sup.4 -NHOH (I)
wherein each of X.sup.1, X.sup.2, X.sup.3 and X.sup.4 is an .alpha.-amino acid residue; the carboxyl group of .alpha.-amino acid X.sup.1 forms a peptide bond together with the amino group of .alpha.-amino acid X.sup.2 ; the carboxyl group of .alpha.-amino acid X.sup.2 forms a peptide bond together with the amino group of .alpha.-amino acid X.sup.3 ; the carboxyl group of .alpha.-amino acid X.sup.3 forms a peptide bond together with the amino group of .alpha.-amino acid X.sup.4 and the carboxyl group of .alpha.-amino acid X.sup.4 forms an amido bond together with --NHOH; and the hydrogen atom of the amino group in .alpha.-amino acid X.sup.1 may be replaced by an aliphatic or aromatic carbyloxycarbonyl or acyl group which itself may have substituents, as well as their salts, are suitable for the purpose mentioned above.
The present inventors have succeeded in providing new compounds of the general formula (I) suitable for the purpose mentioned above by using, as an index, inhibitory action on each of the seven enzymes, i.e. collagenase from human fibroblasts, collagenase from tadpoles, collagenase from bacteria, urease, thermolysin, .alpha.-chymotrypsin and trypsin to screen compounds for strong inhibitory action on the first two enzymes.
The preparation of new peptidylhydroxamic acid derivatives of the general formula (I) are carried out by processes which can be divided roughly into (A) and (B) below:
(A) Process where a compound of the formula Boc-X.sup.4 -NHOBzl is used as starting material; the peptide chain is extended on the Boc-N group side first to form the group X.sup.3 -X.sup.4 -, which is converted, via the group X.sup.2 -X.sup.3 -X.sup.4 - into the group X.sup.1 -X.sup.2 -X.sup.3 -X.sup.4 -; and finally the O-benzyl on the hydroxamic acid side is eliminated to give the desired compound; and
(B) Process where a compound of the formula Boc-X.sup.4 -OR.sup.2 is used as starting material to synthesize the corresponding peptide derivative:
X.sup.1 -X.sup.2 -X.sup.3 -X.sup.4 -OR.sup.2 (R.sup.2 : methyl or ethyl group)
which is then reacted with hydroxylamine to give the desired compound.
In the above mentioned processes, any means conventionally used in the peptide synthetic chemistry may be employed as specific means for condensing amino acids for formation of peptide chains; for protecting with protecting groups the amino, imino, carboxyl and/or hydroxyl groups which may be present in their structure; and for eliminating such protecting groups. Such means is described in detail in the literature for example, in Tanpaku-shitsu Kagaku (Protein chemistry) I, Amino-san (Amino acid).multidot.Peputido (Peptide), ed. by Shiro Akabori, Takeo Kaneko and Kozo Narita, Kyoritsu Shuppan, 1969.
As means for carrying out the condensation mentioned above there may be mentioned a variety of methods, for example, dicyclohexylcarbodiimide (DCC) method, N,N'-dimethylaminopropylethylcarbodiimide (WSCD) method, mixed acid anhydride method, azide method, active ester method, oxidation reduction method and DCC-additive (e.g. 1-hydroxybenzotriazole, N-hydroxysuccinimide and N-hydroxy-5-norbornene-2,3-dicarboxyimide). Where the reaction is carried out using a solvent, there may be used as such solvent N,N-dimethylformamide (DMF), tetrahydrofuran (THF), methylene chloride, dioxane and ethyl acetate or mixtures thereof.
As examples of the protecting groups mentioned above, there may be mentioned benzyloxycarbonyl (Z), t-butyloxycarbonyl (Boc), benzoyl (Bz), acetyl, formyl, p-methoxybenzyloxycarbonyl and trifluoroacetyl for amino or imino group; methyl (OMe), ethyl (OEt), t-butyl, benzyl (OBzl) and p-nitrobenzyl for carboxyl group; and acetyl, benzyl, benzyloxycarbonyl and t-butyl for hydroxyl group. In the foregoing description of compounds or groups, the parenthesized signs are abbreviations standing for such compounds or groups, and these abbreviations are also used as such in the present specification.
As means for eliminating the protecting groups mentioned above, there may be mentioned, for example, catalytic hydrogenation method and methods using trifluoroacetic acid, hydrogen fluoride, hydrogen bromide, hydrogen chloride, sodium hydroxide, potassium hydroxide, etc.
As pharmacologically acceptable salts of compounds of the general formula (I) according to the present invention, there may be mentioned N-addition salts such as hydrochloride, hydrobromide, sulfate, phosphate, formate, acetate, propionate, malonate, succinate, lactate, oxalate and tartarate, and where the amino group is protected, sodium salt, potassium salt, magnesium salt, calcium salt, aluminum salt, piperidine salt, morpholine salt, dimethylamine salt, diethylamine salt, etc.
The new hydroxamic acid derivatives according to the invention have a potent inhibitory action on collagenase derived from vertebrates. In addition these compounds, as well as their metabolites produced in the body, are presumed to have extremely high safety since the components constituting their structure are naturally occurring amino acids of high safety or derivatives thereof.
The following examples are illustrative of the new compounds of the invention as well as of processes for their preparation.
Abbreviations used in the specification including the working examples to represent amino acids and their derivatives or groups present in the structure of these, reagents, etc. are in accordance with signs customarily used in the field of peptide synthetic chemistry (see IUPAC-IUB Commission on Biological Nomenclature), and have the following meanings:
______________________________________Gly: Glycine Ala: AlanineIle: Isoleucine Leu: LeucinePro: Proline Val: ValineSar: Sarcosine Phe: PhenylalanineNle: Norleucine Ser: SerineGlu: Glutamic acid Gln: GlutamineLys: Lysine Arg: ArgininePgl: Phenylglycine Hyp: HydroxyprolinethioPro: Thioproline Asp: Aspartic acidAsn: Asparagine Tyr: ThyrosineTrp: Tryptophane DCC: Dicyclohexyl- carbodiimideHOBt: 1-HydroxybenzotriazoleHOSu: N-HydroxysuccinimideAc: Acetyl Boc: t-ButyloxycarbonylZ: Benzyloxycarbonyl Bz: BenzoylHPA: 2-(p-Hydroxyphenyl)propionylABA: p-Aminobenzoyl PTH: o-PhthalylHBA: p-Hydroxybenzoyl Bzl: Benzyl etherOBzl: Benzyl ester OEt: Ethyl esterOMe: Methyl ester TEA: TriethylamineTHF: Tetrahydrofuran DMF: N,N-dimethyl- formamideDMSO: DimethylsulfoxideTLC: Thin layer chromatography on silica gel______________________________________
Amino acids referred to in the specification, where there can be optical isomers, are in L-form unless otherwise expressly indicated.

EXAMPLE 1
t-Butyloxycarbonyl-glycyl-L-prolyl-L-leucyl-glycylhydroxamic acid (Boc-Bly-Pro-Leu-Gly-NHON)
(A) Synthesis of Boc-Gly-NHOBzl
HCl.multidot.NH.sub.2 OBzl (11.2 g; 70.2 mmol) was suspended in DMF (100 ml) and TEA (11.2 ml; 80.0 mmol) was added dropwise under ice-cooling. HOBt (7.43 g; 55.0 mmol) and Boc-Gly-OH (8.76 g; 50.0 mmol) were then added and the mixture was cooled with a coolant at -20.degree. C. DCC (14.5 g; 70.2 mmol) dissolved in CH.sub.2 Cl.sub.2 (70 ml) was added dropwise. After the dropwise addition, the reaction was allowed to proceed for 1 hour at -10.degree. C. and overnight in a refrigerator. Insolubles were filtered off and the solvent was distilled off under reduced pressure. The residue was dissolved in AcOEt and then washed successively with water, 1N-HCl, water, 10% Na.sub.2 CO.sub.3 and water. The solution was dried over anhydrous MgSO.sub.4 and the solvent was distilled off under reduced pressure. The residue was purified by chromatography on silica gel (Fuji Davison BW 200, 300 g; eluted with AcOEt: n-Hexane (=1:1) mixed solvent) to give Boc-Gly-NHOBzl (13 g; 93%) as a pale yellow oil.
TLC (developing solvent: 1 CHCl.sub.3 :MeOH=14:1, 2 CHCl.sub.3 :MeOH:AcOH=95:5:3; color developing method: 0.1% ninhydrin spraying followed by heating) gave single spots at R.sub.f 1=0.75 and R.sub.f 2=0.63.
(B) Synthesis of HCl.multidot.Gly-NHOBzl
4.5N HCl/AcOEt (30 ml) was added under ice cooling to Boc-Gly-NHOBzl (5.0 g; 17.8 mmol) obtained in (A). The mixture was brought back to room temperature and the reaction was carried out for 1 hour. The solvent was distilled off under reduced pressure and the residue was solidified with Et.sub.2 O to give Hcl.multidot.Gly-NHOBzl (3.60 g; 93%) as a hydroscopic colorless powder.
TLC (developing solvent:1 CHCl.sub.3 :MeOH:AcOH=5:2:1, 2 n-BuOH:AcOH:H.sub.2 O=4:1:1; color developing method: 0.1% ninhydrin spraying followed by heating) gave single spots at R.sub.f 1=0.45 and R.sub.f 2=0.44.
(C) Synthesis of Boc-Leu-Gly-NHOBzl
HCl.multidot.Gly-NHOBzl (7.15 g; 33.0 mmol) obtained in (B) was dissolved in a mixed solvent of DMF (20 ml) and THF (80 ml) and TEA (4.9 ml; 35.0 mmol) was added dropwise under ice cooling. After the dropwise addition, HOBt (4.19 g; 31.0 mmol) and Boc-Leu-OH (product from azeotropic dehydration of the monohydrate (7.48 g; 30.0 mmol)) were added and the mixture was cooled with a coolant at -20.degree. C. After DCC (8.05 g; 39.0 mmol) dissolved in THF (20 ml) was added dropwise, the reaction was carried out for 1 hour at -10.degree. C. and overnight in a refrigerator. Insolubles were removed by filtration and the solvent was distilled off under reduced pressure. The residue was dissolved in AcOEt and washed successively with water, 1N-HCl, water, 10% Na.sub.2 CO.sub.3 and water. The solution was dried over anhydrous MgSO.sub.4 and the solvent was then distilled off under reduced pressure. The residue was purified by chromatography on silica gel (Fuji Davison BW 200, 600 g; eluted with AcOEt: n-hexane (=2:1) mixed solvent) and then recrystallized from AcOEt-n-hexane mixed solvent to give Boc-Leu-Gly-NHOBzl (10.9 g; 93%) as colorless needles.
m.p. 109.degree.-113.degree. C., specific rotation [.alpha.].sub.D.sup.28 -8.3 (c=1.0, EtOH).
TLC (developing solvent:1 CHCl.sub.3 :MeOH=14:1, 2 CHCl.sub.3 :MeOH:AcOH=80:10:5; color developing method: 0.1% ninhydrin spraying followed by heating) gave single spots at R.sub.f 1=0.58 and R.sub.f e,crc/2/ =0.79.
(D) Synthesis of Boc-Gly-Pro-OEt
HCl.multidot.Pro-OEt (10.8 g; 60.1 mmol) was dissolved in THF (70 ml). After TEA (8.4 ml; 60.0 mmol) was added dropwise under ice cooling, HOBt (7.43 g; 55.0 mmol) and Boc-Gly-OH (8.76 g; 50.0 mmol) were added. The mixture was cooled with a coolant at -20.degree. C. and DCC (13.4 g; 65.0 mmol) dissolved in THF (30 ml) was added dropwise. The reaction was carried out for 1 hour at -10.degree. C. and overnight in a refrigerator. Insolubles were removed by filtration and the solvent was distilled off under reduced pressure. The residue was purified by chromatography on silica gel (Fuji Davison BW 200, 250 g; eluted with AcOEt: n-hexane (=3:2) mixed solvent) and then recrystallized from AcOEt-n-hexane to give Boc-Gly-Pro-OEt (10.5 g; 85%) as colorless plates. m.p. 56.5.degree.-57.0.degree. C., specific rotation [.alpha.].sub.D.sup.28 -84.9 (c=1.0, EtOH).
TLC (developing solvent:1 CHCl.sub.3 :MeOH=14:1, 2 CHCl.sub.3 :MeOH:AcOH=80:10:5; color developing method: 0.1% ninhydrin spraying followed by heating) gave single spots at R.sub.f 1=0.73 and R.sub.f 2=0.90.
(E) Synthesis of Boc-Gly-pro-OH
Boc-Gly-Pro-OEt (4.11 g; 15.0 mmol) obtained in (D) was dissolved in MeOH (30 ml). The reaction was carried out for 1 hour after 2N-NaOH (10 ml) was added under ice cooling, and for 4 hours after the mixture was brought back to room temperature. The MeOH was distilled off under reduced pressure and the pH was adjusted to 2 with 1N-HCl The mixture was extracted three times with AcOEt. The extracts were washed with water and dried over anhydrous MgSO.sub.4, and the solvent was distilled off under reduced pressure. The residue was recrystallized from an AcOEt-n-hexane mixed solvent to give Boc-Gly-Pro-OH (3.44 g; 93%) as colorless plates. m.p. 140.5.degree.-141.degree. C., specific rotation [.alpha.].sub.D.sup.28 -75.5 (c=1.0, EtOH).
TLC (developing solvent:1 CHCl.sub.3 :MeOH:AcOH=80:10:5, 2 n-BuOH:AcOH:H.sub.2 O=4:1:1; color developing method: 0.1% ninhydrin spraying followed by heating) gave single spots at R.sub.f 1=0.51 and R.sub.f 2=0.51.
(F) Synthesis of Boc-Gly-Pro-Leu-Gly-NHOBzl
To Boc-Leu-Gly-NHOBzl (3.93 g; 10.0 mmol) obtained in (C) was added under ice cooling 4.5N-HCl/AcOEt (40 ml). The mixture was brought back to room temperature and the reaction was then carried out for 1.5 hours. The solvent was distilled off under reduced pressure and the residue was dissolved in DMF (20 ml) and then cooled with a coolant at -20.degree. C. After TEA (1.4 ml; 10 mmol) was added dropwise, HOBt (1.35 g; 10.0 mmol) and Boc-Gly-Pro-OH (2.34 g; 9.50 mmol) obtained in (E) were added and DCC (2.68 g; 13.0 mmol) dissolved in THF (10 ml) was added dropwise. The reaction was carried out at -10.degree. C. for 1 hour and overnight in a refrigerator. After insolubles were removed by filtration, the solvent was distilled off under reduced pressure and the residue was dissolved in AcOEt and washed successively with water, 1N-HCl, water, 10% Na.sub.2 CO.sub.3 and water. The solution was dried over anhydrous MgSO.sub.4 and the solvent was distilled off under reduced pressure. The residue was purified by chromatography on silica gel (Fuji Davison BW 200, 250 g; eluted with CHCl.sub. 3 :MeOH (=20:1) mixed solvent) to give Boc-Gly-Pro-Leu-Gly-NHOBzl (4.7 g; 90%) as a colorless oil.
Specific rotation [.alpha.].sub.D.sup.28 -68.6 (c=1.0, EtOH).
TLC (developing solvent:1 CHCl.sub.3 :MeOH=14:1, 2 CHCl.sub.3 :MeOH:AcOH=80:10:5; color developing method: 0.1% ninhydrin spraying followed by heating) gave single spots at R.sub.f 1=0.37 and R.sub.f 2=0.72.
(G) Synthesis of Boc-Gly-Pro-Leu-Gly-NHOH
Boc-Gly-Pro-Leu-Gly-NHOBzl (1.0 g; 1.83 mmol) obtained in (F) was dissolved in MeOH (20 ml) and the solution was subjected to catalytic hydrogenation at room temperature for 1 hour using 10% Pd-C (50% wet) (0.3 g). The catalyst was removed by filtration and the solvent was then distilled off under reduced pressure. The residue was purified by chromatography on silica gel (Fuji Davison BW 200, 15 g; eluted with CHCl.sub.3 :MeOH (=20:1) mixed solvent) and then resolidified from CHCl.sub.3 -Et.sub.2 O mixed solvent to give Boc-Gly-Pro-Leu-Gly-NHOH (0.70 g; 84%) as a colorless powder. m.p. 90.degree.-104.degree. C., specific rotation [.alpha.].sub.D.sup.28 -84.3 (c=1.0, EtOH).
TLC (developing solvent:1 CHCl.sub.3 :MeOH:AcOH=80:10:5, 2 n-BuOH:AcOH:H.sub.2 O=4:1:1; color developing method:(a) 0.1% ninhydrin spraying followed by heating, (b) 10% Na.sub.2 CO.sub.3 --and then 5% FeCl.sub.3 --spraying) gave single spots at R.sub.f 1=0.34 and R.sub.f 2=0.67.
EXAMPLE 2
t-ButyloxyCarbonyl-glyCyl-L-prolyl-L-leucyl-L-alanylhydroxamic acid (Boc-Gly-Pro-Leu-Ala-NHOH)
(A) Synthesis of Boc-Ala-NHOBzl
HCl.multidot.NHOBzl (2.07 g; 13.0 mmol) was dissolved in a mixed solvent of DMSO (10 ml) and DMF (30 ml), and TEA (2.0 ml; 14.3 mmol) was added dropwise under ice cooling. After the dropwise addition, HOBt (1.35 g; 10.0 mmol) and Boc-Ala-OH (1.89 g; 10.0 mmol) were added and the mixture was cooled with a coolant at -20.degree. C. DCC (2.70 g; 13.1 mmol) dissolved in CH.sub.2 Cl.sub.2 (10 ml) was added, and the reaction was carried out for 1 hour at -10.degree. C. and overnight in a refrigerator. Insolubles were removed by filtration and the solvent was distilled off under reduced pressure. The residue was dissolved in AcOEt and washed successively with water, 1N-HCl, water, 10% Na.sub.2 CO.sub.3 and water. The solution was dried over anhydrous MgSO.sub.4 and the residue was purified by chromatography on silica gel (Fuji Davison BW 200, 170 g; eluted with AcOEt:n-hexane=2:3 mixed solvent) and then recrystallized from an AcOEt-n-hexane mixed solvent to give Boc-Ala-NHOBzl (2.68 g; 91%) as colorless needles. m.p. 98.degree.-99.degree. C., specific rotation [.alpha.].sub.D.sup.28 -42.1 (c=1.0, EtOH).
TLC (developing solvent:1 CHCl.sub.3 :MeOH=20:1, 2 CHCl.sub.3 :MeOH:AcOH=95:5:3; color developing method: 0.1% ninhydrin spraying followed by heating) gave single spots at R.sub.f 1=0.60 and R.sub.f 2=0.58.
(B) Synthesis Of Boc-Leu-Ala-NHOBzl
To Boc-Ala-NHOBzl (1.47 g; 4.99 mmol) obtained in (A) was added under ice cooling 4.5N-HCl/AcOEt (10 ml). After the mixture was brought back to room temperature, the reaction was carried out for 1 hour. The solvent was distilled off under reduced pressure and the residue was dissolved in THF (20 ml) and cooled with a coolant at -20.degree. C. TEA (0.84 ml; 6.0 mmol) was added dropwise and HOBt (0.68 g; 5.03 mmol) and Boc-Leu-OH (product from azeotropic dehydration with benzene of the monohydrate (1.17 g; 4.69 mmol)) were added. DCC (1.35 g; 6.50 mmol) dissolved in THF (5 ml) was added dropwise, and the reaction was carried out for 1 hour at -10.degree. C. and overnight in a refrigerator. Insolubles were removed by filtration and the solvent was distilled off under reduced pressure. The residue was dissolved in AcOEt and washed successively with water, 1N-HCl, water, 10% Na.sub.2 CO.sub.3 and water. The solution was dried over anhydrous MgSO.sub.4 and the solvent was distilled off under reduced pressure. The residue was solidified from AcOEt to give Boc-Leu-Ala-NHOBzl (1.53 g; 80%) as colorless crystals. m.p. 164.degree.-166.degree. C., specific rotation [.alpha.].sub.D.sup.28 -46.0 (c=1.0, EtOH).
TLC (developing solvent:1 CHCl.sub.3 :MeOH=20:1, 2 CHCl.sub.3 :MeOH:AcOH=95:5:3; color developing method: 0.1% ninhydrin spraying followed by heating) gave single spots at R.sub.f 1=0.52 and R.sub.f 2=0.60.
(C) Synthesis of Boc-Gly-Pro-Leu-Ala-NHOBzl
To Boc-Leu-Ala-NHOBzl (1.37 g; 3.36 mmol) obtained in (B) was added under ice cooling 4.5N-HCl/AcOEt (10 ml). After the mixture was brought back to room temperature the reaction was carried out for 2 hours. The solvent was distilled off under reduced pressure and the residue was dissolved in DMF (10 ml) and cooled with a coolant at -20.degree. C. After TEA (0.49 ml; 3.50 mmol) was added dropwise, HOBt (0.43 g; 3.18 mmol) and Boc-Gly-Pro-OH (0.75 g; 3.05 mmol) obtained in Example 1 (E) were added. DCC (0.83 g; 4.00 mmol) dissolved in THF (5 ml) was added dropwise and the reaction was carried out for 1 hour at -10.degree. C. and overnight in a refrigerator. Insolubles were removed by filtration and the solvent was distilled off under reduced pressure. The residue was dissolved in AcOEt and washed successively with water. 1N-HCl, water, 10% Na.sub.2 CO.sub.3 and water. The solution was dried over anhydrous MgSO.sub.4 and the solvent was distilled off under reduced pressure. The residue was purified by chromatography on silica gel (Fuji Davison BW 200, 100 g; eluted with CHCl.sub.3 :MeOH (=20:1) mixed solvent) and then recrystallized from an AcOEt-n-hexane mixed solvent to give Boc-Gly-Pro-Leu-Ala-NHOBzl (1.32 g; 81%) as colorless crystals. m.p. 103.degree.-105.degree. C., specific rotation [.alpha.].sub.D.sup.28 -72.1 (c=1.0, EtOH).
TLC (developing solvent:1 CHCl.sub.3 :MeOH=14:1, 2 CHCl.sub.3 :MeOH:AcOH=80:10:5; color developing method: 0.1% ninhydrin spraying followed by heating) gave single spots at R.sub.f 1=0.36 and R.sub.f 2=0.80.
(D) Synthesis of Boc-Gly-Pro-Leu-Ala-NHOH
Boc-Gly-Pro-Leu-Ala-NHOBzl (0.53 g; 0.94 mmol) obtained in (C) was dissolved in MeOH (10 ml) and the solution was subjected to catalytic hydrogenation at room temperature for 1 hour using 10% Pd-C (Engelhard 50% wet) (0.17 g). The catalyst was filtered off and the solvent was distilled off under reduced pressure. The residue was resolidified from a MeOH-Et.sub.2 O mixed solvent to give Boc-Gly-Pro-Leu-Ala-NHOH (0.40 g; 86%) as a colorless powder. m.p. 112.degree.-118.degree. C., specific rotation [.alpha.].sub.D.sup.28 -85.0 (c=1.0, EtOH).
TLC (developing solvent:1 CHCl.sub.3 :MeOH:AcOH=80:10:5, 2 n-BuOH:AcOH:H.sub.2 O=4:1:1; color developing method:(a) 0.1% ninhydrin spraying followed by heating, (b) 10% Na.sub.2 CO.sub.3 - and then 5% FeCl.sub.3 - spraying) gave single spots at R.sub.f 1=0.39 and R.sub.f 2=0.67.
EXAMPLE 3
t-Butyloxycarbonyl-glycyl-L-prolyl-L-phenylalanyl-glycylhydroxamic acid (Boc-Gly-Pro-Phe-Gly-NHOH)
(A) Synthesis of Boc-Phe-Gly-NHOBzl
HCl.multidot.Gly-NHOBzl (2.38 g; 11.0 mmol) obtained in Example 1 (B) was dissolved in a mixed solvent of DMF (6 ml) and THF (15 ml), and the solution was cooled with a coolant at -20.degree. C. After TEA (1.54 ml; 11.0 mmol) was added dropwise, HOBt (1.42 g; 10.5 mmol) and Boc-Phe-OH (2.65 g; 10.0 mmol) were added and DCC (2.68 g; 13.0 mmol) dissolved in CH.sub.2 Cl.sub.2 (10 ml) was added dropwise. The reaction was carried out for 1 hour at -10.degree. C. and overnight in a refrigerator. Insolubles were filtered off and the solvent was distilled off under reduced pressure. The residue was dissolved in AcOEt and washed successively with water, 1N-HCl, water, 10% Na.sub.2 CO.sub.3 and water. The solution was dried over anhydrous MgSO.sub.4 and the solvent was distilled off under reduced pressure. The residue was purified by chromatography on silica gel (Fuji Davison BW 200, 100 g; eluted with CHCl.sub.3 :MeOH=50:1 mixed solvent) and solidified from benzene to give Boc-Phe-Gly-NHOBzl (3.75 g; 88%) as a colorless powder. m.p. 71.degree.-72.degree. C., specific rotation [.alpha.].sub.D.sup.28 +9.8 (c=1.0, EtOH).
TLC (developing solvent:1 CHCl.sub.3 :MeOH=14:1, 2 CHCl.sub.3 :MeOH:AcOH=95:5:3; color developing method: 0.1% ninhydrin spraying followed by heating) gave single spots at R.sub.f 1=0.75 and R.sub.f 2=0.62.
(B) Synthesis of Boc-Gly-Pro-Phe-Gly-NHOBzl
To Boc-Phe-Gly-NHOBzl (2.75 g; 6.44 mmol) obtained in (A) was added under ice cooling 4.5N-HCl/AcOEt (20 ml). The mixture was brought back to room temperature and the reaction was carried out for 1 hour. Et.sub.2 O (30 ml) was added and insolubles precipitated thereby were then filtered off and dissolved in DMF (10 ml). The solution was cooled with a coolant at -20.degree. C. and TEA (0.90 ml; 6.44 mmol) was added dropwise. HOBt (0.83 g; 6.14 mmol) and Boc-Gly-Pro-OH (1.59 g; 5.85 mmol) obtained in Example 1 (E) were then added and DCC (1.57 g; 7.61 mmol) dissolved in THF (5 ml) was added dropwise. The reaction was carried out for 1 hour at -10.degree. C. and overnight in a refrigerator. Insolubles were removed by filtration and the solvent was distilled off under reduced pressure. The residue was dissolved in AcOEt and the solution was washed successively in water, 1N-HCl, water, 10% Na.sub.2 CO.sub.3 and water. The solution was dried over anhydrous MgSO.sub.4 and the solvent was distilled off under reduced pressure. The residue was solidified from a small volume of AcOEt to give Boc-Gly-Pro-Phe-Gly-NHOBzl (2.88 g; 85%) as a colorless powder. m.p. 87.degree.-90.degree. C., specific rotation [.alpha.].sub.D.sup.28 -71.8 (c=1.0, EtOH).
TLC (developing solvent:1 CHCl.sub.3 :MeOH=14:1, 2 CHCl.sub.3 :MeOH:AcOH=95:5:3; color developing method: 0.1% ninhydrin spraying followed by heating) gave single spots at R.sub.f 1=0.66 and R.sub.f 2=0.48.
(C) Synthesis of Boc-Gly-pro-Phe-Gly-NHOH
Boc-Gly-Pro-Phe-Gly-NHOBzl (0.80 g; 1.38 mmol) was dissolved in MeOH (10 ml) and the solution was subjected to catalytic hydrogenation at room temperature for 2 hours using 10% Pd-C (Engelhard, 50% wet; 0.14 g). The catalyst was removed by filtration and the solvent was distilled off under reduced pressure. The residue was solidified from a MeOH-Et.sub.2 O mixed solvent to give Boc-Gly-Pro-Phe-Gly-NHOH (0.46 g; 68%) as a colorless powder. m.p. 166.degree.-171.degree. C., specific rotation [.alpha.].sub.D.sup.28 -89.7 (c=1.0, MeOH).
TLC (developing solvent:1 CHCl.sub.3 :MeOH:AcOH=80:10:5, 2 n-BuOH:AcOH:H.sub.2 O=4:1:1; color developing method:(a) 0.1% ninhydrin spraying followed by heating, (b) 10% Na.sub.2 CO.sub.3 --and then 5% FeCl.sub.3 --spraying) gave single spots at R.sub.f 1=0.44 and R.sub.f 2=0.71.
EXAMPLE 4
Benzoyl-glycyl-L-prolyl-L-leucyl-glycyl-hydroxamic acid (Bz-Gly-Pro-Leu-Gly-NHOH)
(A) Synthesis of Bz-Gly-Pro-Leu-Gly-NHOBzl
To Boc-Gly-Pro-Leu-Gly-NHOBzl (0.55 g; 1.00 mmol) obtained in Example 1 (F) was added under ice cooling 4.5N HCl/AcOEt (2 ml), and the mixture was brought back to room temperature. The reaction was carried out for 1 hour. The solvent was distilled off under reduced pressure and the residue was dissolved in DMF (5 ml). The solution was cooled with a coolant at -20.degree. C. and TEA (0.14 ml; 1.00 mmol) was added dropwise. Bz-Cl (0.17 g; 1.21 mmol) was then added dropwise and TEA was used to adjust the pH to 8-9. The reaction was carried out for 1 hour and insolubles were filtered off. The solvent was distilled off under reduced pressure. The residue was dissolved in AcOEt, and the solution was washed successively with water, 1N-HCl, water, 10% Na.sub.2 CO.sub.3 and water and then dried over anhydrous MgSO.sub.4. The solvent was distilled off under reduced pressure and the residue was purified by chromatography on silica gel (Fuji Davison BW 200, 25 g; eluted with CHCl.sub.3 :MeOH (=20:1) mixed solvent) to give Bz-Gly-Pro-Leu-Gly-NHOBzl (0.43 g; 78%) as a colorless powder. m.p. 79.degree.-84.degree. C.,specific rotation [.alpha.].sub.D.sup.28 -69.0 (c=1.0, EtOH).
TLC (developing solvent:1 CHCl.sub.3 :MeOH=14:1, 2 CHCl.sub.3 :MeOH:AcOH=95:5:3; color developing method: 0.1% ninhydrin--and then 47% hydrobromic acid--spraying followed by heating) gave single spots at R.sub.f 1=0.22 and R.sub.f 2=0.65.
(B) Synthesis of Bz-Gly-Pro-Leu-Gly-NHOH
Bz-Gly-Pro-Leu-Gly-NHOBzl (0.30 g; 0.54 mmol) obtained in (A) was dissolved in MeOH (10 ml) and the solution was subjected to catalytic hydrogenation for 3.5 hours at room temperature using 5% Pd-C (Engelhard, 50% wet; 0.10 g). After the catalyst was filtered off, the solvent was distilled off under reduced pressure and the residue was recrystallized from an AcOEt-n-hexane mixed solvent to give Bz-Gly-Pro-Leu-Gly-NHOH (0.16 g; 65%) as a colorless powder. m.p. 118.degree.-123.degree. C., specific rotation [.alpha.].sub.D.sup.28 -77.4 (c=1.0, EtOH).
TLC (developing solvent: 1/ CHCl.sub.3 :MeOH:AcOH=80:10:5, 2 n-BuOH:AcOH:H.sub.2 O=4:1:1; color developing method:(a) 0.1% ninhydrin spraying followed by heating, (b) 10% Na.sub.2 CO.sub.3 --and then 5% FeCl.sub.3 spraying) gave single spots at R.sub.f 1=0.23 and R.sub.f 2=0.60.
EXAMPLE 5
t-Butyloxycarbonyl-glycyl-L-hydroxyprolyl-L-leucyl-glycylhydroxamic acid (Boc-Gly-Hyp-Leu-Gly-NHOH)
(A) Synthesis of Boc-Hyp-Leu-Gly-NHOBzl
To Boc-Leu-Gly-NHOBzl (3.89 g; 9.89 mmol) obtained in Example 1 (C) was added under ice cooling 4.5N-HCl/AcOEt (30 ml), and the solution was brought back to room temperature. The reaction was carried out for 1 hour. The solvent was distilled off under reduced pressure and the residue was dissolved in THF (100 ml). The solution was cooled with a coolant at -20.degree. C. After TEA (1.40 ml; 10.0 mmol) was added dropwise, HOBt (1.22 g; 9.03 mmol) and Boc-Hyp-OH (1.99 g; 8.60 mmol) were added and DCC (2.31 g; 11.2 mmol) dissolved in THF (10 ml) was added dropwise. The reaction was carried out for 1 hour at -10.degree. C. and overnight in a refrigerator. Insolubles were filtered off and the solvent was then distilled off under reduced pressure. The residue was dissolved in AcOEt and the solution was washed successively with water, 1N-HCl, water, 10% Na.sub.2 CO.sub.3 and water and then dried over anhydrous MgSO.sub.4. The solvent was distilled off under reduced pressure and the residue was recrystallized from AcOEt to give Boc-Hyp-Leu-Gly-NHOBzl (2.45 g; 56%) as colorless crystals. m.p. 168.degree.-173.degree. C., specific rotation [.alpha.].sub.D.sup.28 -50.8 (c= 1.0, EtOH).
TLC (developing solvent:1 CHCl.sub.3 :MeOH=14:1. 2 CHCl.sub.3 :MeOH:AcOH=95:5:3; color developing method: 0.1% ninhydrin spraying followed by heating) gave single spots at R.sub.f 1=0.40 and R.sub.f 2=0.19.
(B) Synthesis of Boc-Gly-Hyp-Leu-Gly-NHOBzl
To Boc-Hyp-Leu-Gly-NHOBzl (2.00 g; 3.95 mmol) obtained in (A) was added under ice cooling 4.5N-HCl/AcOEt (10 ml) and the mixture was brought back to room temperature. The reaction was carried out for 1 hour. The precipitate was filtered off and dissolved in DMF (10 ml). TEA (0.55 ml; 3.95 mmol) was added dropwise under ice cooling, and Boc-Gly-ONSu (2.30 g; 7.87 mmol) was added. The mixture was brought back to room temperature and the reaction was carried out for 3 hours. Insolubles were filtered off and the solvent was distilled off under reduced pressure. The residue was dissolved in AcOEt and the solution was washed successively with water, 1N-HCl, water, 10% Na.sub.2 CO.sub.3 and water and then dried over anhydrous MgSO.sub.4. The solvent was distilled off under reduced pressure and the residue was purified by chromatography on silica gel (Fuji Davison BW 200, 100 g; eluted with CHCl.sub.3 :MeOH (=30:1) mixed solvent) to give Boc-Gly-Hyp-Leu-Gly-NHOBzl (1.57 g; 70%) as a colorless oil. Specific rotation [.alpha.].sub.D.sup.28 -55.5 (c=1.0, EtOH).
TLC (developing solvent:1 CHCl.sub.3 :MeOH=14:1, 2 n-BuOH:AcOH:H.sub.2 O=4:1:1; color developing method: 0.1% ninhydrin spraying followed by heating) gave single spots at R.sub.f 1=0.37 and R.sub.f 2=0.64.
(C) Synthesis of Boc-Gly-Hyp-Leu-Gly-NHOH
Boc-Gly-Hyp-Leu-Gly-NHOBzl (0.75 g; 1.33 mmol) obtained in (B) was dissolved in MeOH (10 ml) and the solution was subjected to catalytic hydrogenation for 1 hour at room temperature using 10% Pd-C (Engelhard, 50% wet; 0.25 g). The catalyst was filtered off and the solvent was distilled off under reduced pressure. The residue was resolidified from a MeOH-Et.sub.2 O mixed solvent to give Boc-Gly-Hyp-Leu-Gly-NHOH (0.5 g; 79%) as a colorless powder. m.p. 178.degree.-183.degree. C., specific rotation [.alpha.].sub.D.sup.28 -73.8 (c=1.0, MeOH).
TLC (developing solvent:1 CHCl.sub.3 :MeOH:AcOH=5:2:1, 2 n-BuOH:AcOH:H.sub.2 O=4:1:1; color developing method:(a) 0.1% ninhydrin spraying followed by heating, (b) 10% Na.sub.2 CO.sub.3 --and then 5% FeCl.sub.3 --spraying) gave single spots at R.sub.f 1=0.61 and R.sub.f 2=0.51.
EXAMPLE 6
p-Aminobenzyl-glycyl-L-prolyl-D-leucyl-D-alanyl-hydroxamic acid acetate (AcOH.ABA-Gly-Pro-D-Leu-D-Ala-NHOH)
(A) Synthesis of Z-D-Leu-D-Ala-OMe
HCl.multidot.D-Ala-OMe (5.58 g; 40.0 mmol) was dissolved in DMF (100 ml) and TEA (5.6 ml; 40.0 mmol) was added dropwise under ice cooling. After HOSu (2.30 g; 20.0 mmol) and Z-D-Leu-OH (9.29 g; 35.0 mmol) were added, the mixture was cooled with a coolant at -20.degree. C. and DCC (9.28 g; 45.0 mmol) dissolved in CH.sub.2 CL.sub.2 (50 ml) was added dropwise. The reaction was carried out for 1 hour at -10.degree. C. and overnight in a refrigerator. Insolubles were filtered off and the solvent was distilled off under reduced pressure. The residue was dissolved in AcOEt and the solution was washed successively with water, 1N-HCl, water, 10% Na.sub.2 CO.sub.3 and water and dried over anhydrous MgSO.sub.4. The solvent was distilled off under reduced pressure and the residue was solidified from an Et.sub.2 O-n-hexane mixed solvent to give Z-D-Leu-D-Ala-OMe (11.5 g; 94%) as a colorless powder. m.p. 94.degree.-95.degree. C., specific rotation [.alpha.].sub.D.sup.28 +35.9 (c=1.0, EtOH).
TLC (developing solvent:1 CHCl.sub.3 :MeOH=14:1, 2 CHCl.sub.3 :MeOH:AcOH=95:5:3; color developing method: 0.1% ninhydrin - and then 47% hydrobromic acid spraying followed by heating) gave single spots at R.sub.f 1=0.82 and R.sub.f 2=0.78.
(B) Synthesis of Boc-Pro-D-Leu-D-Ala-OMe
Z-D-Leu-D-Ala-OMe (8.80 g; 25.1 mmol) obtained in (A) was dissolved in MeOH (80 ml) and 4.5N-HCl/AcOEt (10 ml) was added. The mixture was subjected to catalytic hydrogenation for 4 hours at room temperature using 10% Pd-C (Engelhard, 50% wet; 1.2 g). The catalyst was filtered off and the solvent was distilled off under reduced pressure. The residue was dissolved in THF (50 ml) and the solution was cooled with a coolant at -20.degree. C. After TEA (3.50 ml; 25.0 mmol) was added dropwise, HOSu (1.73 g; 15.0 mmol) and Boc-Pro-OH (5.38 g; 25.0 mmol) were added and DCC (6.81 g; 33.0 mmol) dissolved in CH.sub.2 Cl.sub.2 (30 ml) was added dropwise. The reaction was carried out for 1 hour at -10.degree. C. and overnight in a refrigerator. Insolubles were filtered off and the solvent was distilled off under reduced pressure. The residue was dissolved in AcOEt and the solution was washed successively with water, 1N-HCl, water, 10% Na.sub.2 CO.sub.3 and water and dried over anhydrous MgSO.sub.4. The solvent was distilled off under reduced pressure and the residue was solidified from an Et.sub.2 O-n-hexane mixed solvent to give Boc-Pro-D-Leu-D-Ala-OMe (8.27 g; 85%) as a colorless powder. m.p. 153.degree.-157.degree. C., specific rotation [.alpha.].sub.D.sup.28 +11.6 (c=1.0, EtOH).
TLC (developing solvent:1 CHCl.sub.3 :MeOH=14:1, 2 CHCl.sub.3 :MeOH:AcOH=95:5:3; color developing method: 0.1% ninhydrin spraying followed by heating) gave single spots at R.sub.f 1=0.80 and R.sub.f 2=0.63.
(C) Synthesis Of Z-Gly-Pro-D-Leu-D-Ala-OMe
To Boc-Pro-D-Leu-D-Ala-OMe (4.13 g; 10.0 mmol) obtained in (B) was added under ice cooling 4.5N-HCl/AcOEt (30 ml) and the mixture was brought back to room temperature and the reaction was carried out for 1.5 hours. The solvent was distilled off under reduced pressure and the residue was dissolved in DMF (30 ml). The solution was cooled with a coolant at -20.degree. C. After TEA (1.40 ml; 10.0 mmol) was added dropwise, HOSu (0.58 g; 5.04 mmol) and Z-Gly-OH (2.10 g; 10.0 mmol) were added and DCC (2.60 g; 12.6 mmol) dissolved in CH.sub.2 Cl.sub.2 (10 ml) was added dropwise. The reaction was carried out for 1 hour at -10.degree. C. and overnight in a refrigerator. Insolubles were filtered off and the solvent was distilled off under reduced pressure. The residue was dissolved in AcOEt and the solution was washed successively with water, 1N-HCl, water, 10% Na.sub.2 CO.sub.3 and water and dried over anhydrous MgSO.sub.4. The solvent was distilled off under reduced pressure and the residue was recrystallized from an AcOEt-Et.sub.2 O mixed solvent to give Z-Gly-Pro-D-Leu-D-Ala-OMe (3.95 g; 78%) as colorless crystals. m.p. 130.degree.-134.degree. C., specific rotation [.alpha.].sub.D.sup.28 +11.8 (c=1.0, EtOH).
TLC (developing solvent:1 CHCl.sub.3 :MeOH=14:1, 2 CHCl.sub.3 :MeOH:AcOH=95:5:3; color developing method: 0.1% ninhydrin - and then 47% hydrobromic acid spraying followed by heating) gave single spots at R.sub.f 1=0.74 and R.sub.f 2=0.58.
(D) Synthesis of Z-ABA-Gly-Pro-D-Leu-D-Ala-OMe
Z-Gly-Pro-D-Leu-D-Ala-OMe (2.00 g; 3.96 mmol) obtained in (C) was dissolved in MeOH (10 ml) and the solution was subjected to catalytic hydrogenation at room temperature for 2 hours using 10% Pd-C (Engelhard, 50% wet; 0.50 g). The catalyst was filtered off and the solvent was distilled off under reduced pressure. The residue was dissolved in DMF (15 ml) and the solution was cooled with a coolant at -20.degree. C. HOBt (0.27 g; 2.00 mmol) and Z-ABA-OH (1.09 g; 4.02 mmol) were added in that order, and DCC (1.03 g; 4.99 mmol) dissolved in CH.sub.2 Cl.sub.2 (5 ml) was added dropwise. The reaction was carried out for 1 hour at -10.degree. C. and overnight in a refrigerator. Insolubles were filtered off and the solvent was distilled off under reduced pressure. The residue was dissolved in AcOEt and the solution was washed successively with water, 1N-HCl, water, 10% Na.sub.2 CO.sub.3 and water and dried over anhydrous MgSO.sub.4. The solvent was distilled off under reduced pressure and the residue was recrystallized from AcOEt to give Z-ABA-Gly-Pro-D-Leu-D-Ala-OMe (1.78 g; 72%) as a colorless powder. m.p. 109.degree.-112.degree. C., specific rotation [.alpha.].sub.D.sup.28 +4.7 (c=1.0, EtOH).
TLC (developing solvent:1 CHCl.sub.3 :MeOH=14:1, 2/ CHCl.sub.3 :MeOH:AcOH=95:5:3; color developing method: 0.1% ninhydrin--and then 47% hydrobromic acid--spraying followed by heating) gave single spots at R.sub.f 1=0.65 and R.sub.f 2=0.46.
(E) Synthesis of Z-ABA-Gly-Pro-D-Leu-D-Ala-NHOH
To Z-ABA-Gly-Pro-D-Leu-D-Ala-OMe (1.68 g; 2.69 mmol) obtained in (D) was added under ice cooling a separately prepared 1M NH.sub.2 OH/MeOH solution [i.e. a solution obtained by adding dropwise under ice cooling NH.sub.2 OH.HCl (0.63 g; 9.06 mmol) dissolved in MeOH (4 ml) to a solution of KOH (1.00 g; 85%; 15.1 mmol) in MeOH (3 ml) and filtering off the precipitated KCl] (6 ml) and the reaction was carried out for 4 hours. 3N-HCl was used to adjust the pH to 2 and the precipitate was filtered off to give Z-ABA-Gly-Pro-D-Leu-D-Ala-NHOH (1.68 g; quantitative) as a colorless powder. m.p. 189.degree.-191.degree. C., specific rotation [.alpha.].sub.D.sup.28 +10.4 (c=1.0, EtOH).
TLC (developing solvent:1 CHCl.sub.3 :MeOH=14:1, 2 CHCl.sub.3 :MeOH:AcOH=95:5:3; color developing method: (a) 0.1% ninhydrin--and then 47% hydrobromic acid spraying followed by heating, (b) 10% Na.sub.2 CO.sub.3 --and then 5% FeCl.sub.3 spraying) gave single spots at R.sub.f 1=0.40 and R.sub.f 2=0.14.
(F) Synthesis of AcOH.ABA-Gly-Pro-D-Leu-D-Ala-NHOH
Z-ABA-Gly-Pro-D-Leu-D-Ala-NHOH (1.40 g; 2.24 mmol) obtained in (E) was dissolved in an AcOH:water (=2:1) mixed solvent (10 ml) and the solution was subjected to catalytic hydrogenation at room temperature for 2.5 hours using 10% Pd-C (Engelhard, 50% wet; 0.35 g). The catalyst was distilled off and the solvent was distilled off under reduced pressure. The residue was recrystallized from EtOH to give AcOH.ABA-Gly-Pro-D-Leu-D-Ala-NHOH (0.93 g; 75%) as a colorless powder. m.p. 213.degree.-218.degree. C., specific rotation [.alpha.].sub.D.sup.28 +23.4 (c=0.5, H.sub.2 O).
TLC (developing solvent:1 CHCl.sub.3 :MeOH:AcOH=80:0:5, 2 n-BuOH:AcOH:H.sub.2 O=4:1:1; color developing method:(a) 0.1% ninhydrin spraying followed by heating, (b) 10% Na.sub.2 CO.sub.3 --and then 5% FeCl.sub.3 --spraying) gave single spots at R.sub.f 1=0.25 and R.sub.f 2=0.58.
EXAMPLE 7
p-Hydroxybenzoyl-glycyl-L-prolyl-D-leucyl-D-alanylhydroxamic acid (HBA-Gly-Pro-D-Leu-D-Ala-NHOH)
(A) Synthesis of Bzl-HBA-Gly-Pro-D-Leu-D-Ala-OMe
Z-Gly-Pro-D-Leu-D-Ala-OMe (1.73 g; 3.43 mmol) obtained in Example 6 (C) was dissolved in MeOH (5 ml) and the solution was subjected to catalytic hydrogenation at room temperature for 2 hours using 10% Pd-C (Engelhard, 50% wet; 0.30 g). The catalyst was filtered off and the solvent was distilled off under reduced pressure. The residue was dissolved in DMF (10 ml) and cooled with a coolant at -20.degree. C. Bzl-HBA-Cl [prepared by dissolving Bzl-HBA-OH (1.17 g; 5.15 mmol) in SOCl.sub.2 (5 ml), heating the solution under reflux for 3 hours and distilling off the excess SOCl.sub.2 under reduced pressure] dissolved in DMF (3 ml) was added dropwise. TEA was used to adjust the pH to 8 and the reaction was carried out for 4 hours. Insolubles were filtered off and the solvent was distilled off under reduced pressure. The residue was dissolved in AcOEt and the solution was washed successively with water, 1N-HCl, water, 10% Na.sub.2 CO.sub.3 and water and dried over anhydrous MgSO.sub.4. The solvent was distilled off under reduced pressure and the residue was subjected to chromatography on silica gel (Fuji Davison BW 200, 15 g; eluted with AcOEt) to give Bzl-HBA-Gly-Pro-D-Leu-D-Ala-OMe (1.23 g; 62%) as a colorless oil. Specific rotation [.alpha.].sub.D.sup.28 +4.6 (c=1.0, EtOH).
TLC (developing solvent:1 CHCl.sub.3 :MeOH=14:1, 2 CHCl.sub.3 :MeOH:AcOH=95:5:3; color developing method: 0.1% ninhydrin--and then 47% hydrobromic acid--spraying followed by heating) gave single spots at R.sub.f 1=0.73 and R.sub.f 2=0.58.
(B) Synthesis of Bzl-HBA-Gly-Pro-D-Leu-D-Ala-NHOH
To Bzl-HBA-Gly-Pro-D-Leu-D-Ala-OMe (1.15 g; 1.98 mmol) obtained in (A) was added under ice cooling 1M-NH2OH/MeOH (5 ml) prepared in the same manner as in Example 6 (E) and the reaction was carried out for 3 hours. 3N-HCl was used to adjust the pH to 2 and the precipitate was filtered off and resolidified from a MeOH-Et.sub.2 O mixed solvent to give Bzl-HBA-Gly-Pro-D-Leu-D-Ala-NHOH (0.87 g; 76%) as a colorless powder. m.p. 181.degree.-184.degree. C., specific rotation [.alpha.].sub.D.sup.28 +13.6 (c=1.0, EtOH).
TLC (developing solvent:1 CHCl.sub.3 :MeOH=14:1, 2 CHCl.sub.3 :MeOH:AcOH=95:5:3; color developing method: (a) 0.1% ninhydrin--and then 47% hydrobromic acid--spraying followed by heating, (b) 10% Na.sub.2 CO.sub.3 --and then 5% FeCl.sub.3 - spraying) gave single spots at R.sub.f 1=0.51 and R.sub.f 2=0.25.
(C) Synthesis of HBA-Gly-Pro-D-Leu-D-Ala-NHOH
Bzl-HBA-Gly-Pro-D-Leu-D-Ala-NHOH (0.83 g; 1.43 mmol) obtained in (B) was dissolved in MeOH (5 ml) and the solution was subjected to catalytic hydrogenation at room temperature for 2 hours using 10% Pd-C (Engelhard, 50% wet; 0.15 g). The catalyst was filtered off and the solvent was distilled off under reduced pressure. The residue was solidified from a MeOH-Et.sub.2 O mixed solvent to give HBA-Gly-Pro-D-Leu D Ala-NHOH (0.53 g; 76%) as a colorless powder. m.p. 159.degree.-164.degree. C., specific rotation [.alpha.].sub.D.sup.28 +12.6 (c=0.5, EtOH).
TLC (developing solvent:1 CHCl.sub.3 :MeOH:AcOH=80:10:5, 2 n-BuOH:AcOH:water=4:1:1; color developing method:(a) 0.1% ninhydrin--and then 47% hydrobromic acid spraying followed by heating, (b) 10% Na.sub.2 CO.sub.3 --and then 5% FeCl.sub.3 --spraying) gave single spots at R.sub.f 1=0.27 and R.sub.f 2=0.67.
EXAMPLES 8-42
In accordance with the procedure as described in Examples 1-7, the compounds indicated in Table 1 were prepared. Data for the compounds obtained in the respective Examples are as shown in Table 1.
TABLE 1__________________________________________________________________________Example Compound Process forNo. (as indicated by formula) m.p. .degree.C. [.alpha.].sub.D.sup.28 TLC:R.sub.f.sup.1) synthesis__________________________________________________________________________ 8 HCl.GlyProLeuGlyNHOH hygroscopic -87.2(c = 0.5, EtOH) .sup.3 0.24 A 9 HCl.SarProLeuGlyNHOH hygroscopic -79.1(c = 1.0, EtOH) .sup.2 0.19 A10 AcGlyProLeuGlyNHOH 109.about.115 -91.3(c = 1.0, EtOH) .sup.1 0.13.sup.2 A.4311 ##STR1## hygroscopic -72.6(c = 0.5, EtOH) .sup.1 0.09.sup.2 A.4512 BocSarProLeuGlyNHOH 94.about.99 -80.6(c = 1.0, EtOH) .sup.1 0.42.sup.2 A.6613 AcSarProLeuGlyNHOH hygroscopic -88.2(c = 0.5, EtOH) .sup.1 0.15.sup.2 A.3714 ##STR2## hygroscopic -73.8(c = 0.5, EtOH) .sup.1 0.54.sup.2 A.7115 BocGlyProLeu-.beta.-AlaNHOH 108.about.112 -70.2(c = 1.0, EtOH) .sup.1 0.38.sup.2 A.6416 BocGlyProLeuGABNHOH 88.about.93 -56.9(c = 1.0, EtOH) .sup.1 0.38.sup.2 A.6417 BocGlyProLeu-D-AlaNHOH 115.about.120 -89.3(c = 1.0, EtOH) .sup.1 0.55.sup.2 A.7018 BocGlyProLeuValNHOH 118.about.123 -113.6(c = 1.0, EtOH) .sup.1 0.53.sup.2 A.7319 HCl.GlyProLeu-.beta.-AlaNHOH hygroscopic -21.8(c = 1.0, EtOH) .sup.3 0.27 A20 HCl.GlyProLeuGABNHOH hygroscopic -51.5(c = 1.0, EtOH) .sup.3 0.22 A21 BocGlyPro-D-LeuGlyNHOH 96.about.100 -20.3(c = 1.0, EtOH) .sup.1 0.50.sup.2 A.7322 BocGlyProGlnGlyNHOH hygroscopic -67.1(c = 1.0, EtOH) .sup.1 0.08.sup.2 A.4323 BocGlyProGluGlyNHOH 94.about.100 -64.9(c = 1.0, EtOH) .sup.1 0.12.sup.2 A.4924 BocGlyProGlyGlyNHOH 178.about.180 -52.3(c = 1.0, DMF) .sup.1 0.16.sup.2 A.4425 BocGlyProIleGlyNHOH 126.about.129 -78.3(c = 1.0, EtOH) .sup.1 0.37.sup.2 A.6426 BocGlyProSerGlyNHOH 101.about.105 -72.1(c = 1.0, EtOH) .sup.1 0.12.sup.2 A.4527 BocGlyProLysGlyNHOH hygroscopic -56.5(c = 1.0, EtOH) .sup.2 0.25 A28 BocGlyProProGlyNHOH hygroscopic -98.1(c = 1.0, EtOH) .sup.1 0.31.sup.20.46 A29 ##STR3## hygroscopic -65.2(c = 1.0, H.sub.2 O) .sup.4 0.16 A30 BocGlyGlyLeuGlyNHOH 126.about.129 -12.5(c = 1.0, EtOH) .sup.1 0.18.sup.2 A.6531 BocGlyAlaLeuGlyNHOH 149.about.152 -42.2(c = 1.0, EtOH) .sup.1 0.24.sup.2 A.6732 BzGly-D-ProLeuGlyNHOH 99.about.105 + 18.4(c = 1.0, EtOH) .sup.1 0.55.sup.2 A.7033 BzGly-thioProLeuGlyNHOH 166.about.169 -96.8(c = 0.5, MeOH) .sup.1 0.30.sup.2 A.6734 BzGlyProLeuAlaNHOH 202.about.204 -71.7(c = 1.0, DMF) .sup.1 0.78.sup.2 A.7535 BzGlyPro-D-Leu-D-AlaNHOH 172.about.174 +10.8(c = 1.0, DMF) .sup.1 0.63.sup.2 A.7036 BzGlyProLeuSarNHOH 107.about.110 -94.5(c = 1.0, EtOH) .sup.1 0.44.sup.2 A.5837 BzGlyPro-D-L-SarNHOH 116.about.119 -36.9(c = 1.0, DMF) .sup.1 0.49.sup.2 A.6038 BzGlyProLeuLeuNHOH 131.about.135 -74.0(c = 0.5, EtOH) .sup.1 0.35.sup.2 A.6639 BzGlyPro-D-Leu-D-LeuNHOH 187.about.190 +25.6(c = 0.5, EtOH) .sup.1 0.69.sup.2 A.7440 PTHGlyPro-D-Leu-D-LeuNHOH 159.about.164 +17.8(c = 0.5, EtOH) .sup.1 0.15.sup.2 A.5141 AcOH.ABAGlyProLeuAlaNHOH 229.about.232 -116(c = 1.0, AcOH:H.sub.2 O = .sup.1 0.08.sup.2 B.4542 BzGlyProLeu-D-AlaNHOH 119.about.123 -98.1(c = 1.0, DMF) .sup.1 0.4920.66 A__________________________________________________________________________ .sup.1) developing solvent: .sup.1 CHCl.sub.3 :MeOH:AcOH = 80:10:5 .sup.2 n-BuOH:AcOH:H.sub.2 O = 4:1:1 .sup.3 n-BuOH:AcOH:H.sub.2 O = 4:2:1 .sup.4 n-BuOH:AcOH:H.sub.2 O = 4:3:3 Color developing method: (a) 0.1% ninhydrin and then 47% hydrobromic acid spraying followed by heating. (b) 10% Na.sub.2 CO.sub.3 - and then 5% FeCl.sub.3 -spraying
Using the following procedures, the new peptide compounds of the invention were assayed for inhibitory activity against collagenases as well as against other enzymes:
(1) Inhibitory activity against collagenases
The inhibitory activity against human fibroblast collagenase (collagenase derived from human fibroblasts), tadpole-derived collagenase and bacteria (Clostridium)-derived collagenase was assayed in accordance with the method of Nagai [see Ensho, 4(2), 123 (1984)] using a fluorescence-labeled collagen (FITC-derivatized bovine type I collagen).
(2) Inhibitory activity against urease
The inhibitory activity against urease was assayed in accordance with the method of Kobashi et al. [see Biochem. Biophys. Acta, 227 429 (1971)] using sword bean-derived urease.
(3) Inhibitory activity against thermolysin, trypsin and .alpha.-chymotrypsin
This was assayed in accordance with the method of Laskowski [see Meth. Enzymol., 2, 8 (1955)] using a thermally denatured casein as substrate for the respective enzymes (i.e. thermolysin, trypsin and .alpha.-chymotrypsin).
Results of these assays are shown in Table 2.
TABLE 2__________________________________________________________________________IC.sub.50 (.mu.M)Human Inhibition (%) fibroblast Tadpole BacterialExample collage- collage- collage .alpha.-Chymo-No. nase nase nase Urease Thermolysin Trypsin trypsin__________________________________________________________________________6 1.28 1.10 7.1%/ 2.0%/ 26.8%/ 6.5%/ 26.4%/ 2.0 .times. 10.sup.-4 M 4.0 .times. 10.sup.-3 M 4.0 .times. 10.sup.-3 M 2.0 .times. 10.sup.-3 2.0 .times. 10.sup.-3 M7 1.18 1.05 20.9%/ 5.3%/ 60.4%/ 56.1%/ 22.3%/ 4.0 .times. 10.sup.-3 M 4.0 .times. 10.sup.-3 M 4.0 .times. 10.sup.-3 M 4.0 .times. 10.sup.-3 4.0 .times. 10.sup.-3 M18 3.1 9.8 50.0%/ 22.0%/ 50.0%/ 0%/ 0%/ 3.4 .times. 10.sup.-2 M 2.0 .times. 10.sup.-2 M 1.01 .times. 10.sup.-2 M 4.0 .times. 10.sup.- 3 4.0 .times. 10.sup.-3 M34 2.7 7.7 34.0%/ 0%/ 35.0%/ 0%/ 0%/ 1.2 .times. 10.sup.-3 M 4.0 .times. 10.sup.-3 M 4.0 .times. 10.sup.-3 M 2.0 .times. 10.sup.-4 2.0 .times. 10.sup.-4 M35 6.4 3.1 33.0%/ 24.0%/ 38.0%/ 2.2%/ 12.8%/ 3.0 .times. 10.sup.-3 M 3.0 .times. 10.sup.-3 M 4.0 .times. 10.sup.-3 M 1.0 .times. 10.sup.-4 1.0 .times. 10.sup.-4 M40 3.6 3.1 20.7%/ 3.3%/ 32.2%/ 21.6%/ 22.3%/ 4.0 .times. 10.sup.-3 M 4.0 .times. 10.sup.-3 M 4.0 .times. 10.sup.-3 M 1.0 .times. 10.sup.-2 1.0 .times. 10.sup.-2 M41 3.7 4.0 0%/ 3.3%/ 4.0%/ 14.4%/ 27.3%/ 5.0 .times. 10.sup.-5 M 3.4 .times. 10.sup.-5 M 2.0 .times. 10.sup.-5 M 2.0 .times. 10.sup.- 5 2.0 .times. 10.sup.-5__________________________________________________________________________ M
The new peptides of the invention are extremely useful since they are found to have a specific inhibitory activity against collagenase as compared to known peptide substances.
The toxicity of the new peptide compounds of this invention is as follows:
Acute toxicity test (LD.sub.50) in mice
______________________________________Compound LD.sub.50(as indicated by Intraperitoneal IntravenousExample No.) administration administration______________________________________6 >2 g/kg >200 mg/kg7 >2 g/kg >200 mg/kg41 >2 g/kg >200 mg/kg______________________________________

Number	Name	Date
4568666	McCullagh et al.	Feb 1986
4595700	Donald et al.	Jun 1986
4599361	Dickens et al.	Jul 1986
4681966	Donald et al.	Jul 1987
4687841	Spilburg et al.	Aug 1987
4720486	Spilburg et al.	Jan 1988
4743587	Dickens et al.	May 1988

Number	Date	Country
61-103896	May 1986	JPX
61-152650	Jul 1986	JPX
62-103052	May 1987	JPX

Hydroxamic acid tetrapeptide derivatives

Information

Patent Number

Date Filed

Date Issued

Inventors

Original Assignees

Examiners

Agents

CPC

US Classifications

Field of Search

US

International Classifications

Abstract

Description

Claims

Priority Claims (1)

PCT Information

US Referenced Citations (7)

Foreign Referenced Citations (3)